Ledger.Open graph →
SEC Form D · filed February 2, 2018

Prellis Biologics, Inc

Offering
$1.0M
Sold
$460K
Exemption
Rule 506(b)
Industry
Biotechnology
Location
SAN FRANCISCO, CA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (11)

Arvind Gupta · San Francisco, CADirectorRohit Sharma · San Francisco, CADirectorMelanie Matheu · San Francisco, CAExec · DirectorDaniel J. Mavico · Charlotte, NCDirectorPaul Hallenbeck · Blue Bell, PADirectorAdam Taback · Charlotte, NCExec · DirectorNoelle Mullin · San Francisco, CAExec · DirectorMarco Alfonsi · HICKSVILLE, NYDirectorNitesh Kumar · Princeton, NJExec · DirectorLongTail Alpha LLC · Newport Beach, CADirectorNoelle Mullin · San Francisco, CAExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗